Does Maternal High-dose Vitamin D Supplementation During Pregnancy Increase Linear Growth Among Infants at One Year? - A Systematic Review and Meta-analysis

Page: [49 - 58] Pages: 10

  • * (Excluding Mailing and Handling)

Abstract

Background: In pregnancy, maternal vitamin D deficiency has been associated with adverse birth outcomes worldwide and has become a major public health concern. However, the linkage between maternal prenatal vitamin D status and post-natal linear growth, particularly in infancy, is inconclusive and ambiguous.

Objective: This study aims to systematically identify, appraise, and synthesize available evidence regarding the effect of maternal vitamin D supplementation on infants’ linear growth at one year.

Methods: A systematic electronic search of Medline and Embase databases was undertaken from the OVID platform. The risk of bias in the selected studies was assessed using the risk of bias (RoB) tool introduced and recommended by the Cochrane Collaboration.

Results: A quantitative synthesis (meta-analysis) was conducted using RevMan. After screening, only two studies fulfilled the eligibility criteria, comprising a total of 593 infants: (296 from mothers receiving vitamin D and 297 from mothers receiving placebo). One RCT found a 0.8 cm gain in length whereas the second RCT found infants to be 0.23 cm shorter compared to their placebo counterparts. A meta-analysis also could not detect a significant difference in length. However, the pooled result favored infants (0.19 cm taller) born to mothers receiving prenatal vitamin D.

Conclusion: The quality of overall evidence for the outcome ‘infant length at 1 year’-as assessed using the GRADE approach was low. Maternal high-dose vitamin D supplementation during pregnancy increases linear growth in infants at 12 months of age, but, this increase is very small and not statistically significant.

Keywords: Vitamin D, supplementation, pregnancy, linear growth, infant, linear growth.

Graphical Abstract

[1]
Black RE, Heidkamp R. Causes of stunting and preventive dietary interventions in pregnancy and early childhood. Nestle Nutr Inst Workshop Ser 2018; 89: 105-13.
[http://dx.doi.org/10.1159/000486496] [PMID: 29991036]
[2]
UNICEF. World Bank Group. Levels and trends in child malnutrition: Joint child malnutrition estimates. Key findings of the 2017 edition 2018.
[3]
de Onis M, Branca F. Childhood stunting: a global perspective. Matern Child Nutr 2016; 12 (Suppl. 1): 12-26.
[http://dx.doi.org/10.1111/mcn.12231] [PMID: 27187907]
[4]
Dewey KG, Begum K. Long-term consequences of stunting in early life. Matern Child Nutr 2011; 7 (Suppl. 3): 5-18.
[http://dx.doi.org/10.1111/j.1740-8709.2011.00349.x] [PMID: 21929633]
[5]
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G, Vitamin D. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev 2016; 96(1): 365-408.
[http://dx.doi.org/10.1152/physrev.00014.2015] [PMID: 26681795]
[6]
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81.
[http://dx.doi.org/10.1056/NEJMra070553] [PMID: 17634462]
[7]
Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26(10): 2341-57.
[8]
Sackett D, Richardson W, Rosenberg W, Haynes RJNYCL. How to practice and teach evidence-based medicine 1997; 118-28.
[9]
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336(7651): 995-8.
[http://dx.doi.org/10.1136/bmj.39490.551019.BE] [PMID: 18456631]
[10]
De‐Regil LM, Palacios C, Lombardo LK, Peña‐Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews 2016; 1.
[11]
Higgins JP, Green S, Eds. Cochrane Handbook for Systematic Reviews of Intervention. West Sussex, England: John Wiley & Sons Ltd 2008.
[http://dx.doi.org/10.1002/9780470712184]
[12]
Collaboration C. Review manager (RevMan) version 53. Copenhagen: The Nordic Cochrane Centre 2014.
[13]
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials BMJ 2011; 343(oct18 2): d5928.
[http://dx.doi.org/10.1136/bmj.d5928] [PMID: 22008217]
[14]
Brooke OG, Butters F, Wood C. Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br Med J (Clin Res Ed) 1981; 283(6298): 1024.
[http://dx.doi.org/10.1136/bmj.283.6298.1024] [PMID: 6794748]
[15]
Roth DE, Morris SK, Zlotkin S, et al. Vitamin D supplementation in pregnancy and lactation and infant growth. N Engl J Med 2018; 379(6): 535-46.
[http://dx.doi.org/10.1056/NEJMoa1800927] [PMID: 30089075]
[16]
Roth DE, Perumal N, Al Mahmud A, Baqui AH. Maternal vitamin D3 supplementation during the third trimester of pregnancy: effects on infant growth in a longitudinal follow-up study in Bangladesh. J Pediatr 2013; 163(6): 1605-1611.e3.
[http://dx.doi.org/10.1016/j.jpeds.2013.07.030] [PMID: 23998516]
[17]
Roth DE, Al Mahmud A, Raqib R, et al. Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial. Nutr J 2013; 12(1): 47.
[http://dx.doi.org/10.1186/1475-2891-12-47] [PMID: 23587190]
[18]
Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001; 323(7303): 42-6.
[http://dx.doi.org/10.1136/bmj.323.7303.42] [PMID: 11440947]
[19]
Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012; 10(1): 28-55.
[http://dx.doi.org/10.1016/j.ijsu.2011.10.001] [PMID: 22036893]
[20]
Morgan GA, Gliner JA, Harmon RJ. Research approaches, questions, and designs Understanding and evaluating research in applied and clinical Settings. Mahwah, NJ: Lawrence Erlbaum Associates 2006; pp. 69-110.
[21]
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64(4): 401-6.
[http://dx.doi.org/10.1016/j.jclinepi.2010.07.015] [PMID: 21208779]
[22]
GRADE Working Group. GRADEpro GDT: GRADEpro Guideline Development Tool McMaster University. Developed by Evidence Prime, Inc. 2015.
[23]
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539-58.
[http://dx.doi.org/10.1002/sim.1186] [PMID: 12111919]
[24]
Bi WG, Nuyt AM, Weiler H, Leduc L, Santamaria C, Wei SQ. Association between vitamin D supplementation during pregnancy and offspring growth, morbidity, and mortality: a systematic review and meta-analysis. JAMA Pediatr 2018; 172(7): 635-45.
[http://dx.doi.org/10.1001/jamapediatrics.2018.0302] [PMID: 29813153]
[25]
Brown P, Brunnhuber K, Chalkidou K, et al. How to formulate research recommendations. BMJ 2006; 333(7572): 804-6.
[http://dx.doi.org/10.1136/bmj.38987.492014.94] [PMID: 17038740]